| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/01/2006 | EP1620095A2 Inhibitors of akt activity |
| 02/01/2006 | EP1620092A2 Compounds, compositions, and methods |
| 02/01/2006 | EP1620088A2 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 02/01/2006 | EP1620070A2 Toll-like receptor 9 effector agents and uses thereof |
| 02/01/2006 | EP1620066A2 Oral care methods and products |
| 02/01/2006 | EP1620061A2 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/01/2006 | EP1620060A2 Methods and devices for the sustained release of multiple drugs |
| 02/01/2006 | EP1620059A2 Delivery systems of homogeneous, thermoreversible gel film containing kappa-2 carrageenan |
| 02/01/2006 | EP1620058A2 Composition for improving cognition and memory |
| 02/01/2006 | EP1620057A2 Modified heat-generating cosmetic compositions |
| 02/01/2006 | EP1620056A2 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 02/01/2006 | EP1620038A2 Drug releasing biodegradable fiber for delivery of therapeutics |
| 02/01/2006 | EP1619951A2 Methods and compositions for treating disorders |
| 02/01/2006 | EP1104289B1 New oral formulation for 5-ht4 agonists or antagonists |
| 02/01/2006 | EP0906119B1 Stimulation of host defense mechanisms against cancer |
| 02/01/2006 | EP0759297B1 Remedy for pulmonary heart |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1729014A Disease treatment via antimicrobial peptide inhibitors |
| 02/01/2006 | CN1729013A Broad spectrum anti-viral therapeutics and prophylaxis |
| 02/01/2006 | CN1729006A Treatment for reactive arthritis or bursitis |
| 02/01/2006 | CN1729004A Ester combination local anesthetic |
| 02/01/2006 | CN1728993A Pharmaceutical composition comprising lumiracoxib |
| 02/01/2006 | CN1239152C Therapeutic formulation for administering tolterodine with controlled release |
| 01/31/2006 | US6992104 C7 carbonate taxane compositions |
| 01/31/2006 | US6992071 Methods for modulating phototoxicity |
| 01/31/2006 | US6991807 Four different dosage forms, two antibiotics inhibiting protein and non-protein synthesis, one comprising immediate release and sustained release, the other three has sustained release forms, twenty-four hour period; bacterial infections |
| 01/31/2006 | US6991640 Nosebleed lip pack |
| 01/31/2006 | CA2490335C Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 01/26/2006 | WO2006009501A1 Prevention of allergy in children |
| 01/26/2006 | WO2005048931A3 Dissolving thin film xanthone supplement |
| 01/26/2006 | WO2005046605A3 Compositions and methods of treating neurological diseases |
| 01/26/2006 | WO2005037233A3 Listeria-based epha2 vaccines |
| 01/26/2006 | WO2005037205A3 Haloacetamide and azide substituted compounds and methods of use thereof |
| 01/26/2006 | WO2005030146A3 Calcium dietary supplement |
| 01/26/2006 | WO2005016230A3 Evaluating protein signatures |
| 01/26/2006 | WO2005011589A3 Drug delivery methods and devices |
| 01/26/2006 | WO2005009354A3 Compositions of a cyclooxygenase-2 selective inhibitor and an ikk inhibitor for the treatment of ischemic-mediated central nervous system disorders or injury |
| 01/26/2006 | WO2004108087A3 Gene delivery to organs |
| 01/26/2006 | WO2004100874A3 Androgen receptor modulators and methods of use thereof |
| 01/26/2006 | WO2004098534A3 Methods for delivering angiogenic modulators using pox viruses |
| 01/26/2006 | WO2004098532A3 Methods of reducing an immune response |
| 01/26/2006 | WO2004045532A3 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 01/26/2006 | WO2004014319A3 Screening strategy for anticancer drugs |
| 01/26/2006 | US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 01/26/2006 | US20060020000 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/26/2006 | US20060019931 Treating bone-related disorders with selective androgen receptor modulators |
| 01/26/2006 | US20060019918 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 01/26/2006 | US20060019882 Use of Yops as caspase inhibitor |
| 01/26/2006 | US20060019239 enhancing the immunogenicity of a vaccine against Bacillus anthracis by administering an oligodeoxynucleotide with a vaccine against Bacillus anthracis; Anthrax Vaccine Adsorbed (AVA) vaccine |
| 01/26/2006 | US20060018951 pH-responsive film for intravaginal delivery of a beneficial agent |
| 01/26/2006 | US20060018836 Method for treating human tumor cells with a newcastle disease virus strain having a p53 independent oncolytic effect |
| 01/26/2006 | CA2574093A1 Prevention of allergy in children |
| 01/25/2006 | EP1619498A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 01/25/2006 | EP1618373A2 Apparatus and method to measure platelet contractility |
| 01/25/2006 | EP1618106A2 Carbacephem -lactam antibiotics |
| 01/25/2006 | EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1618086A2 Compounds for the treatment of metabolic disorders |
| 01/25/2006 | EP1617955A2 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease |
| 01/25/2006 | EP1617876A1 Thorium-227 for use in radiotherapy of soft tissue disease |
| 01/25/2006 | EP1617871A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 01/25/2006 | EP1617863A2 Compositions and methods for wt1 specific immunotherapy |
| 01/25/2006 | EP1617857A2 Pharmaceutical compositions for treating painful neuropathy and methods of treating same |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617850A2 Delivery vehicle for silver ions |
| 01/25/2006 | EP1617848A2 Anti-cancer phosphonate conjugates |
| 01/25/2006 | EP1617847A2 Methods for the controlled delivery of pharmacologically active compounds |
| 01/25/2006 | EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/25/2006 | EP1617835A2 Compounds for the treatment of metabolic disorders |
| 01/25/2006 | EP1617830A2 Esterified fatty acid composition |
| 01/25/2006 | EP1617829A2 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/25/2006 | EP1617825A2 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 01/25/2006 | EP1617822A2 Tablets and methods for modified release of hydrophilic and other active agents |
| 01/25/2006 | EP1617815A2 Process for making gel films |
| 01/25/2006 | EP1617810A2 Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 01/25/2006 | EP1617808A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 01/25/2006 | EP1617807A2 Substituted 1,4-diazepines and uses thereof |
| 01/25/2006 | EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators |
| 01/25/2006 | EP1617805A2 Methods of preventing or treating respiratory conditions |
| 01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 01/25/2006 | EP1617802A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 01/25/2006 | EP1617799A2 Hemophilia treatment by inhalation of coagulation factors |
| 01/25/2006 | EP1617723A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof |
| 01/25/2006 | EP1617722A2 Treating hepatocellular carcinomas using therapeutic viruses |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726216A C-6 modified indazolylpyrrolotriazines |
| 01/25/2006 | CN1726198A Compounds, compositions, and methods |
| 01/25/2006 | CN1725997A A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 01/25/2006 | CN1725996A A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 01/25/2006 | CN1724066A Controlled release composition and method of producing the same |
| 01/25/2006 | CN1238353C Amino acid ester containing azole antifungal agent |
| 01/24/2006 | US6989400 Treatment of benign prostatic hyperplasia |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989380 Treatment of pain |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/24/2006 | CA2186193C Cosmetic compositions containing tricholine citrate |
| 01/19/2006 | WO2006006929A1 Infusion and injection solution of levodopa |
| 01/19/2006 | WO2005039506A3 P70s6 kinase modulators and method of use |
| 01/19/2006 | WO2005030130A3 Isoquinoline potassium channel inhibitors |
| 01/19/2006 | WO2005000202A3 Compositions and methods for the modulation of the expression of b7 protein |